Design and synthesis of novel pyrimido[4,5-b]azepine derivatives as HER2/EGFR dual inhibitorsYouichi Kawakita, Tomoyasu Ishikawa, Toshimasa Tanaka et al.|Bioorganic & Medicinal Chemistry|2013Cited by 79
Design and Synthesis of Pyrrolo[3,2-<i>d</i>]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket BindersYouichi Kawakita, Tomoyasu Ishikawa, Hiroshi Banno et al.|Journal of Medicinal Chemistry|2012Cited by 44
Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: Improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacyYouichi Kawakita, Tomoyasu Ishikawa, Kazuhiro Miwa et al.|Bioorganic & Medicinal Chemistry|2012Cited by 29
Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis ModelAkiko Nakayama, Yoshikazu Ohta, Shinji Takagi et al.|Journal of Cancer|2013Cited by 25